We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current PAHC market cap is 911.33M. The company's latest EPS is USD 0.0596 and P/E is 377.18.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 249.94M | 263.22M | 273.16M | 260.43M | 309.26M |
| Operating Income | 15.7M | 19.92M | 18.42M | 17.7M | 25.53M |
| Net Income | 1.27M | 8.41M | 752k | 6.98M | 3.19M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 800.35M | 833.35M | 942.26M | 977.89M | 1.02B |
| Operating Income | 69.19M | 74.87M | 78.99M | 71.85M | 53.32M |
| Net Income | 33.55M | 54.39M | 49.18M | 32.61M | 2.42M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 972.71M | 979.04M | 982.18M | 966.29M | 1.29B |
| Total Liabilities | 701.91M | 708.94M | 725.54M | 707.76M | 1.04B |
| Total Equity | 270.8M | 270.09M | 256.64M | 258.53M | 246.8M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 784.1M | 841.33M | 931.7M | 971.4M | 982.18M |
| Total Liabilities | 595.9M | 602.8M | 669.26M | 688.89M | 725.54M |
| Total Equity | 188.2M | 238.53M | 262.44M | 282.51M | 256.64M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 47.76M | 59.17M | 87.59M | 12.62M | 15.7M |
| Investing | -40.21M | -39.08M | -48.19M | -2.93M | -263.4M |
| Financing | -13.41M | -8.56M | -6.77M | -29.2M | 247.12M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 59.35M | 48.31M | 31.65M | 13.31M | 87.59M |
| Investing | -120.39M | -18.58M | -22.58M | -74.02M | -48.19M |
| Financing | 40.94M | -17M | 16.34M | 26.99M | -6.77M |
| Market Cap | 911.33M |
| Price to Earnings Ratio | 377.18 |
| Price to Sales Ratio | 0.89 |
| Price to Cash Ratio | 12.89 |
| Price to Book Ratio | 3.55 |
| Dividend Yield | 2.13% |
| Shares Outstanding | 40.5M |
| Average Volume (1 week) | 349.65k |
| Average Volume (1 Month) | 272.66k |
| 52 Week Change | 85.19% |
| 52 Week High | 26.55 |
| 52 Week Low | 11.90 |
| Spread (Intraday) | 4.08 (16.94%) |
| Company Name | Phibro Animal Health Corporation |
| Address |
111 8th avenue new york 10011 |
| Website | https://www.pahc.com |
| Industry | gen farms-lvstk, animal spec (0291) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
